These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

415 related items for PubMed ID: 26511019

  • 1. Correlation of 4'-[methyl-(11)C]-thiothymidine uptake with Ki-67 immunohistochemistry and tumor grade in patients with newly diagnosed gliomas in comparison with (11)C-methionine uptake.
    Tanaka K, Yamamoto Y, Maeda Y, Yamamoto H, Kudomi N, Kawai N, Toyohara J, Nishiyama Y.
    Ann Nucl Med; 2016 Feb; 30(2):89-96. PubMed ID: 26511019
    [Abstract] [Full Text] [Related]

  • 2. Correlation of 4'-[methyl-11C]-thiothymidine PET with Ki-67 immunohistochemistry separately in patients with newly diagnosed and recurrent gliomas.
    Norikane T, Mitamura K, Yamamoto Y, Hatakeyama T, Miyake K, Toyohara J, Nishiyama Y.
    Nucl Med Commun; 2021 Dec 01; 42(12):1322-1327. PubMed ID: 34284440
    [Abstract] [Full Text] [Related]

  • 3. Correlation of 18F-FDG and 11C-methionine uptake on PET/CT with Ki-67 immunohistochemistry in newly diagnosed intracranial meningiomas.
    Mitamura K, Yamamoto Y, Norikane T, Hatakeyama T, Okada M, Nishiyama Y.
    Ann Nucl Med; 2018 Nov 01; 32(9):627-633. PubMed ID: 30032455
    [Abstract] [Full Text] [Related]

  • 4. Correlation of 4'-[methyl-11C]-thiothymidine uptake with human equilibrative nucleoside transporter-1 and thymidine kinase-1 expressions in patients with newly diagnosed gliomas.
    Takami Y, Yamamoto Y, Ueno M, Chiba Y, Norikane T, Hatakeyama T, Miyake K, Toyohara J, Nishiyama Y.
    Ann Nucl Med; 2018 Nov 01; 32(9):634-641. PubMed ID: 30039191
    [Abstract] [Full Text] [Related]

  • 5. 4'-[Methyl-11C]-thiothymidine PET/CT for proliferation imaging in non-small cell lung cancer.
    Minamimoto R, Toyohara J, Seike A, Ito H, Endo H, Morooka M, Nakajima K, Mitsumoto T, Ito K, Okasaki M, Ishiwata K, Kubota K.
    J Nucl Med; 2012 Feb 01; 53(2):199-206. PubMed ID: 22190643
    [Abstract] [Full Text] [Related]

  • 6. 11C-methionine (MET) and 18F-fluorothymidine (FLT) PET in patients with newly diagnosed glioma.
    Hatakeyama T, Kawai N, Nishiyama Y, Yamamoto Y, Sasakawa Y, Ichikawa T, Tamiya T.
    Eur J Nucl Med Mol Imaging; 2008 Nov 01; 35(11):2009-17. PubMed ID: 18542957
    [Abstract] [Full Text] [Related]

  • 7. Glioma proliferation as assessed by 3'-fluoro-3'-deoxy-L-thymidine positron emission tomography in patients with newly diagnosed high-grade glioma.
    Ullrich R, Backes H, Li H, Kracht L, Miletic H, Kesper K, Neumaier B, Heiss WD, Wienhard K, Jacobs AH.
    Clin Cancer Res; 2008 Apr 01; 14(7):2049-55. PubMed ID: 18381944
    [Abstract] [Full Text] [Related]

  • 8. Intratumoral heterogeneity of 18F-FLT uptake predicts proliferation and survival in patients with newly diagnosed gliomas.
    Mitamura K, Yamamoto Y, Kudomi N, Maeda Y, Norikane T, Miyake K, Nishiyama Y.
    Ann Nucl Med; 2017 Jan 01; 31(1):46-52. PubMed ID: 27686469
    [Abstract] [Full Text] [Related]

  • 9. 4'-[methyl-11C]-thiothymidine as a proliferation imaging tracer for detection of colorectal cancer: comparison with 18F-FDG.
    Fukuda Y, Yamamoto Y, Mitamura K, Ishikawa R, Asano E, Toyohara J, Norikane T, Nishiyama Y.
    Ann Nucl Med; 2019 Nov 01; 33(11):822-827. PubMed ID: 31401773
    [Abstract] [Full Text] [Related]

  • 10. Correlation of 6-18F-fluoro-L-dopa PET uptake with proliferation and tumor grade in newly diagnosed and recurrent gliomas.
    Fueger BJ, Czernin J, Cloughesy T, Silverman DH, Geist CL, Walter MA, Schiepers C, Nghiemphu P, Lai A, Phelps ME, Chen W.
    J Nucl Med; 2010 Oct 01; 51(10):1532-8. PubMed ID: 20847166
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. 18F-fluoro-L-thymidine and 11C-methylmethionine as markers of increased transport and proliferation in brain tumors.
    Jacobs AH, Thomas A, Kracht LW, Li H, Dittmar C, Garlip G, Galldiks N, Klein JC, Sobesky J, Hilker R, Vollmar S, Herholz K, Wienhard K, Heiss WD.
    J Nucl Med; 2005 Dec 01; 46(12):1948-58. PubMed ID: 16330557
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. [Combined use of positron emission tomography with (18)F-fluorodeoxyglucose and (11)C-methionine for preoperative evaluation of gliomas].
    Yamaguchi S, Terasaka S, Kobayashi H, Narita T, Hirata K, Shiga S, Usui R, Tanaka S, Kubota K, Murata J, Asaoka K.
    No Shinkei Geka; 2010 Jul 01; 38(7):621-8. PubMed ID: 20628188
    [Abstract] [Full Text] [Related]

  • 18. Prognostic value of post-treatment metabolic tumor volume from 11C-methionine PET/CT in recurrent malignant glioma.
    Jung TY, Min JJ, Bom HS, Jung S, Kim IY, Lim SH, Kim DY, Kwon SY.
    Neurosurg Rev; 2017 Apr 01; 40(2):223-229. PubMed ID: 27282449
    [Abstract] [Full Text] [Related]

  • 19. Metabolic mapping of gliomas using hybrid MR-PET imaging: feasibility of the method and spatial distribution of metabolic changes.
    Bisdas S, Ritz R, Bender B, Braun C, Pfannenberg C, Reimold M, Naegele T, Ernemann U.
    Invest Radiol; 2013 May 01; 48(5):295-301. PubMed ID: 23296081
    [Abstract] [Full Text] [Related]

  • 20. Correlation of amino-acid uptake using methionine PET and histological classifications in various gliomas.
    Torii K, Tsuyuguchi N, Kawabe J, Sunada I, Hara M, Shiomi S.
    Ann Nucl Med; 2005 Dec 01; 19(8):677-83. PubMed ID: 16444993
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.